{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:09:28Z","timestamp":1767845368307,"version":"3.49.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>A subgroup of patients with Major Depressive Disorder shows signs of low-grade inflammation and metabolic abberances, while antidepressants can induce weight gain and subsequent metabolic disorders, and lacking antidepressant response is associated with inflammation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>A comprehensive investigation of patient phenotypes and their predictive capability for weight gain and treatment response after psychotropic treatment will be performed. The following factors will be analyzed: inflammatory and metabolic markers, gut microbiome composition, lifestyle indicators (eating behavior, physical activity, chronotype, patient characteristics (childhood adversity among others), and polygenic risk scores.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Psychiatric inpatients with at least moderate Major Depressive Disorder will be enrolled in a prospective, observational, naturalistic, monocentric study using stratified sampling. Ethical approval was obtained. Primary outcomes at 4 weeks will be percent weight change and symptom score change on the Montgomery Asberg Depression Rating Scale. Both outcomes will also be binarized into clinically relevant outcomes at 5% weight gain and 50% symptom score reduction. Predictors for weight gain and treatment response will be tested using multiple hierachical regression for continuous outcomes, and multiple binary logistic regression for binarized outcomes. Psychotropic premedication, current medication, eating behavior, baseline BMI, age, and sex will be included as covariates. Further, a comprehensive analysis will be carried out using machine learning. Polygenic risk scores will be added in a second step to estimate the additional variance explained by genetic markers. Sample size calculation yielded a total amount of N = 171 subjects.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>Patient and physician expectancies regarding the primary outcomes and non-random sampling may affect internal validity and external validity, respectively. Through the prospective and naturalistic design, results will gain relevance to clinical practice. Examining the predictive value of patient profiles for weight gain and treatment response during pharmacotherapy will allow for targeted adjustments before and concomitantly to the start of treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0271793","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T17:42:24Z","timestamp":1658425344000},"page":"e0271793","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comprehensive approach to predicting weight gain and therapy response in psychopharmacologically treated major depressed patients: A cohort study protocol"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-2772","authenticated-orcid":true,"given":"Maria S.","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara B.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Glocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-8413","authenticated-orcid":true,"given":"Richard","family":"Musil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"issue":"2","key":"pone.0271793.ref001","first-page":"123","article-title":"Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder","volume":"34","author":"KL Chan","year":"2019","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"pone.0271793.ref002","doi-asserted-by":"crossref","first-page":"437","DOI":"10.12740\/PP\/76863","article-title":"Inflammatory theory of depression","volume":"52","author":"P Ga\u0142ecki","year":"2018","journal-title":"Psychiatr Pol."},{"issue":"6","key":"pone.0271793.ref003","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","article-title":"Is depression an inflammatory disorder?","volume":"13","author":"CL Raison","year":"2011","journal-title":"Curr Psychiatry Rep."},{"issue":"1","key":"pone.0271793.ref004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41398-020-00979-z","article-title":"Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression","volume":"10","author":"C Schiweck","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"12","key":"pone.0271793.ref005","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/obr.12934","article-title":"Effects of antidepressant and antipsychotic use on weight gain: A systematic review","volume":"20","author":"L Alonso-Pedrero","year":"2019","journal-title":"Obes Rev.Dec"},{"key":"pone.0271793.ref006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpsychires.2018.10.021","article-title":"Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort","volume":"107","author":"K El Asmar","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"11","key":"pone.0271793.ref007","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"AJ Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"pone.0271793.ref008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jad.2018.12.037","article-title":"Inflammatory profiles of severe treatment-resistant depression","volume":"246","author":"R Strawbridge","year":"2019","journal-title":"J Affect Disord"},{"issue":"18","key":"pone.0271793.ref009","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/01.CIR.0000164203.54111.AE","article-title":"Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"111","author":"JP Empana","year":"2005","journal-title":"Circulation"},{"issue":"1\u20133","key":"pone.0271793.ref010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2011.05.047","article-title":"Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression\u2014no influence of celecoxib treatment","volume":"134","author":"R Musil","year":"2011","journal-title":"J Affect Disord"},{"issue":"3","key":"pone.0271793.ref011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archpsyc.58.3.221","article-title":"Depression and cardiac mortality: results from a community-based longitudinal study","volume":"58","author":"BW Penninx","year":"2001","journal-title":"Arch Gen PsychiatryMar"},{"key":"pone.0271793.ref012","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cellimm.2018.03.001","article-title":"Adipose tissue macrophages and their polarization in health and obesity","volume":"330","author":"L Catrysse","year":"2018","journal-title":"Cell Immunol"},{"issue":"2","key":"pone.0271793.ref013","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"M Carabotti","year":"2015","journal-title":"Ann Gastroenterol."},{"key":"pone.0271793.ref014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fpsyt.2017.00153","article-title":"\"I Am I and My Bacterial Circumstances\": Linking Gut Microbiome, Neurodevelopment, and Depression","volume":"8","author":"JM Lima-Ojeda","year":"2017","journal-title":"Front Psychiatry"},{"issue":"6","key":"pone.0271793.ref015","doi-asserted-by":"crossref","first-page":"e36889","DOI":"10.1371\/journal.pone.0036889","article-title":"Changes in body weight and psychotropic drugs: a systematic synthesis of the literature","volume":"7","author":"R Dent","year":"2012","journal-title":"PLoS One"},{"key":"pone.0271793.ref016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2016.11.056","article-title":"Insight gained from genome-wide interaction and enrichment analysis on weight gain during citalopram treatment","volume":"637","author":"HT Corfitsen","year":"2017","journal-title":"Neurosci Lett"},{"issue":"2","key":"pone.0271793.ref017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"JP Domecq","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"pone.0271793.ref018","doi-asserted-by":"crossref","first-page":"e1417","DOI":"10.4088\/JCP.14m09358","article-title":"Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment","volume":"76","author":"F Vandenberghe","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"pone.0271793.ref019","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0269881114555250","article-title":"Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female rats","volume":"28","author":"Q Zhang","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"2","key":"pone.0271793.ref020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00210-013-0933-5","article-title":"Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects","volume":"387","author":"EM Girault","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"pone.0271793.ref021","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: A meta-analysis","volume":"25","author":"R Strawbridge","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"pone.0271793.ref022","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","article-title":"Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium","volume":"10","author":"G Arteaga-Henr\u00edquez","year":"2019","journal-title":"Front Psychiatry"},{"issue":"12","key":"pone.0271793.ref023","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/jgs.15129","article-title":"Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance","volume":"65","author":"JS Mulvahill","year":"2017","journal-title":"J Am Geriatr Soc."},{"issue":"7","key":"pone.0271793.ref024","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/npp.2014.9","article-title":"Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users","volume":"39","author":"N Vogelzangs","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"pone.0271793.ref025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0706743719900464","article-title":"Gut Microbiome Patterns Associated With Treatment Response in Patients With Major Depressive Disorder","volume":"65","author":"A Bharwani","year":"2020","journal-title":"Can J Psychiatry"},{"key":"pone.0271793.ref026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2019.12.020","article-title":"The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness","volume":"264","author":"A Madan","year":"2020","journal-title":"J Affect Disord"},{"issue":"10","key":"pone.0271793.ref027","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1038\/tp.2015.135","article-title":"Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children","volume":"5","author":"SM Bahr","year":"2015","journal-title":"Transl Psychiatry"},{"issue":"11","key":"pone.0271793.ref028","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ebiom.2015.10.018","article-title":"Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure","volume":"2","author":"SM Bahr","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"pone.0271793.ref029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41398-018-0116-8","article-title":"Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota","volume":"8","author":"AC Kao","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"12","key":"pone.0271793.ref030","doi-asserted-by":"crossref","first-page":"e115225","DOI":"10.1371\/journal.pone.0115225","article-title":"The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse","volume":"9","author":"AP Morgan","year":"2014","journal-title":"PLoS One"},{"key":"pone.0271793.ref031","article-title":"Predicting psychopharmaco-induced weight gain using machine learning algorithms. [PowerPoint Presentation].","author":"R Musil","journal-title":"Department of Psychiatry and Psychotherapy, University hospital, LMU Munich. [Bilateral NCNP-MPI-LMU Workshop, Munich 2017 Oct 16"},{"key":"pone.0271793.ref032","doi-asserted-by":"crossref","first-page":"587486","DOI":"10.3389\/fpsyt.2020.587486","article-title":"The Psychology of Food Cravings in Patients With First-Episode Psychosis","volume":"11","author":"YH Kim","year":"2020","journal-title":"Front Psychiatry"},{"key":"pone.0271793.ref033","article-title":"Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain associated medication","author":"MS Simon","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"pone.0271793.ref034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41537-017-0018-4","article-title":"Dopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances","volume":"3","author":"Z Freyberg","year":"2017","journal-title":"NPJ Schizophr."},{"issue":"48","key":"pone.0271793.ref035","doi-asserted-by":"crossref","first-page":"E6691","DOI":"10.1073\/pnas.1519807112","article-title":"Shifting eating to the circadian rest phase misaligns the peripheral clocks with the master SCN clock and leads to a metabolic syndrome","volume":"112","author":"A Mukherji","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0271793.ref036","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/obr.12621","article-title":"Meta-analysis on shift work and risks of specific obesity types","volume":"19","author":"M Sun","year":"2018","journal-title":"Obes Rev."},{"key":"pone.0271793.ref037","volume-title":"Time-To-Eat: A pilot study on a circadian diet [Master`s thesis]","author":"I. Wilming","year":"2020"},{"key":"pone.0271793.ref038","article-title":"SKID. Strukturiertes Klinisches Interview f\u00fcr DSM-IV Achse I und II","author":"H-U Wittchen","year":"1997","journal-title":"Handanweisung. G\u00f6ttingen: Hogrefe"},{"key":"pone.0271793.ref039","volume-title":"WHO STEPwise approach to surveillance (STEPS)","author":"WHO","year":"2008"},{"issue":"16","key":"pone.0271793.ref040","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Eckel RH Alberti KGMM","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"pone.0271793.ref041","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-2362.2007.01888.x","article-title":"Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular M\u00fcnster (PROCAM) study","volume":"37","author":"G Assmann","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"pone.0271793.ref042","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"AJ Rush","year":"1996","journal-title":"Psychol Med."},{"issue":"4","key":"pone.0271793.ref043","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mpr.226","article-title":"The Inventory of Depressive Symptomatology: German translation and psychometric validation","volume":"16","author":"T Drieling","year":"2007","journal-title":"Int J Methods Psychiatr Res."},{"key":"pone.0271793.ref044","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"SA Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"2","key":"pone.0271793.ref045","first-page":"51","article-title":"Untersuchungen zur Reliabilit\u00e4t und Validit\u00e4t einer deutschen Version der Montgomery-Asberg Depression-Rating Scale (MADRS) [Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)]","volume":"139","author":"A Schmidtke","year":"1988","journal-title":"Schweiz Arch Neurol Psychiatr (1985)"},{"key":"pone.0271793.ref046","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12955-015-0235-3","article-title":"Hamilton depression rating scale and montgomery-asberg depression rating scale in depressed and bipolar I patients: psychometric properties in a Brazilian sample","volume":"13","author":"AM Carneiro","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"pone.0271793.ref047","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0033291707001730","article-title":"Measuring depression: comparison and integration of three scales in the GENDEP study","volume":"38","author":"R Uher","year":"2008","journal-title":"Psychol Med."},{"issue":"15","key":"pone.0271793.ref048","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jpsychires.2010.03.006","article-title":"Response and remission criteria in major depression\u2014a validation of current practice","volume":"44","author":"M Riedel","year":"2010","journal-title":"J Psychiatr Res"},{"issue":"2","key":"pone.0271793.ref049","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","article-title":"Development and validation of a brief screening version of the Childhood Trauma Questionnaire","volume":"27","author":"DP Bernstein","year":"2003","journal-title":"Child Abuse Negl"},{"issue":"2","key":"pone.0271793.ref050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0031-1295495","article-title":"Die deutsche Version des Childhood Trauma Questionnaire (CTQ)\u2014psychometrische Eigenschaften in einer bev\u00f6lkerungsrepr\u00e4sentativen Stichprobe [The German Version of the Childhood Trauma Questionnaire (CTQ): psychometric characteristics in a representative sample of the general population]","volume":"62","author":"G Klinitzke","year":"2012","journal-title":"Psychother Psychosom Med Psychol."},{"issue":"1","key":"pone.0271793.ref051","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","article-title":"The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger","volume":"29","author":"AJ Stunkard","year":"1985","journal-title":"J Psychosom Res"},{"key":"pone.0271793.ref052","volume-title":"Handanweisung","author":"V Pudel","year":"1989"},{"issue":"6","key":"pone.0271793.ref053","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ijo.2009.74","article-title":"Psychometric analysis of the Three-Factor Eating Questionnaire-R21: results from a large diverse sample of obese and non-obese participants","volume":"33","author":"JC Cappelleri","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"pone.0271793.ref054","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0748730402239679","article-title":"Life between clocks: daily temporal patterns of human chronotypes","volume":"18","author":"T Roenneberg","year":"2003","journal-title":"J Biol Rhythms"},{"key":"pone.0271793.ref055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/bs.mie.2014.11.028","article-title":"Human activity and rest in situ","volume":"552","author":"T Roenneberg","year":"2015","journal-title":"Methods Enzymol"},{"key":"pone.0271793.ref056","doi-asserted-by":"crossref","first-page":"569864","DOI":"10.3389\/fpsyt.2020.569864","article-title":"DAILY-A Personalized Circadian Zeitgeber Therapy as an Adjunctive Treatment for Alcohol Use Disorder Patients: Study Protocol for a Randomized Controlled Trial","volume":"11","author":"A H\u00fchne","year":"2021","journal-title":"Front Psychiatry"},{"issue":"9","key":"pone.0271793.ref057","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/07420528.2011.613137","article-title":"Circadian preference and sleep-wake regularity: associations with self-report sleep parameters in daytime-working adults","volume":"28","author":"AM Soehner","year":"2011","journal-title":"Chronobiol Int."},{"issue":"1","key":"pone.0271793.ref058","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S2215-0366(15)00496-4","article-title":"Ward PB; International Working Group. The Simple Physical Activity Questionnaire","volume":"3","author":"S Rosenbaum","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"pone.0271793.ref059","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12888-020-2473-0","article-title":"Assessing physical activity in people with mental illness: 23-country reliability and validity of the simple physical activity questionnaire (SIMPAQ)","volume":"20","author":"S Rosenbaum","year":"2020","journal-title":"BMC Psychiatry"},{"key":"pone.0271793.ref060","article-title":"NeuroMiner","author":"MS Dong","journal-title":"Version 1.0"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T17:43:42Z","timestamp":1658425422000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271793"}},"subtitle":[],"editor":[{"given":"Carla","family":"Pegoraro","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0271793","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,21]]}}}